trans-Complementation of HBV rtM204I mutant replication by HBV wild-type polymerase.

Virology

Department of Microbiology and Immunology, Milton S. Hershey Medical Center, The Penn State College of Medicine, Hershey, PA 17033, USA.

Published: May 2009

The function of the hepatitis B virus (HBV) wild-type (WT) polymerase (pol) expressed alone or in the context of the intact genome when interacting with HBV rtM204I in HepG2 cells was compared. We show that WT pol expression from a packaging-defective RNA can complement defective rtM204I pol activity resulting in increased levels of HBV replicative intermediates (RI). Analysis of the genetically marked genomes showed that this restoration resulted from trans-complementation, rather than recombination. In contrast, we demonstrate that enhanced levels of total HBV RI observed when cells were cotransduced with both WT and rtM204I baculoviruses were predominantly WT RI. In this case, WT pol was produced from a full-length pregenomic RNA (pgRNA). We conclude that the WT pol has the capacity to trans-complement the replication defect of rtM204I; however, when expressed from an authentic pgRNA, as in a mixed infection, pol may not trans-complement efficiently.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670753PMC
http://dx.doi.org/10.1016/j.virol.2009.03.018DOI Listing

Publication Analysis

Top Keywords

hbv rtm204i
8
hbv wild-type
8
wild-type polymerase
8
pol
6
rtm204i
5
hbv
5
trans-complementation hbv
4
rtm204i mutant
4
mutant replication
4
replication hbv
4

Similar Publications

Evaluation of genotype characteristics and drug resistance mutations in patients with chronic hepatitis B.

Sci Rep

November 2024

Department of Clinical Laboratory, Chongqing Qianjiang Central Hospital, Qianjiang Key Laboratory of Chongqing Qianjiang Central Hospital Laboratory Medicine, Chongqing University Qianjiang Hospital, No. 360 South Section, Zhengzhou Road, Qianjiang District, Chongqing, 409000, China.

Hepatitis B is one of the public health priorities worldwide, especially in the Southwest China. Our study aimed to investigate the relationship between genotypes and drug resistance mutations among HBV patients in Southwest China, with the objective of providing guidance for clinical antiviral treatment. A total of 4266 chronic hepatitis B (CHB) patients treated in the Qianjiang Hospital of Chongqing University were included in our study from 2014 to 2020.

View Article and Find Full Text PDF

Background And Aim: Hepatitis B virus (HBV) reactivation could develop after withdrawal following a finite course of nucleoside analog (NA) therapy, leading to virological and clinical relapses. The genetic heterogeneity in the HBV surface and polymerase genes during finite NA therapy has not been carefully studied.

Methods: Seven chronic HBV-infected patients experiencing relapses following entecavir (ETV; n = 5; Patients 1 to 5) or tenofovir disoproxil fumarate (TDF; n = 2; Patients 6 and 7) withdrawal were included.

View Article and Find Full Text PDF

Aim: Patients with chronic hepatitis B virus (HBV) infection experiencing viral breakthrough (BTH) or partial response (PR) during lamivudine (LAM) or entecavir hydrate (ETV) administration often took ETV plus tenofovir alafenamide fumarate (TAF) due to the emergence of a drug-resistance mutation. However, in patients lacking drug-resistance mutation against TAF, sufficient antiviral effects may be achievable with TAF monotherapy. We assessed the drug-resistance profile through nucleotide sequences of HBV pregenome RNA, and subsequently changed to TAF monotherapy from ETV plus TAF.

View Article and Find Full Text PDF
Article Synopsis
  • * Using Sanger and next-generation sequencing, researchers found a mean HBV viral load in serum and identified various genotypes (with A1 being the most common at 55%).
  • * While there was a 100% agreement in genotypes between serum and oral fluid, only 80% agreement was found with DBS, revealing some genotypic differences and the presence of a resistance mutation in all individuals.
View Article and Find Full Text PDF

The central nervous system is a potential reservoir and possible origin of drug resistance in hepatitis B infection.

J Virus Erad

September 2023

Department of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

Background: The significance of hepatitis B virus (HBV) in cerebrospinal fluid (CSF) is unclear.

Methods: Synchronous serum and CSF samples were collected from 13 patients. HBV DNA, full-length genome, quasispecies, phylogenetic tree, compartmentalization and mutation of the reverse transcriptase (RT) region were performed based on PCR and sequencing methods.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!